Skip to Content
Biotechnology and health

How US experts helped China build a DNA surveillance state

February 21, 2019

China has been leaning on American know-how to build a sprawling surveillance program in Xinjiang province, according to the New York Times

Crack down: Chinese authorities have created “a vast Chinese campaign of surveillance and oppression” targeting Uighurs, an ethnic minority who are mostly Muslims and live in the northwestern province. A comprehensive DNA database is part of the plan to keep the restive group under control.

American role: Scientists working with Chinese police have been using equipment from Thermo Fisher, a supplier of biotechnology tools in Massachusetts. They also shared genetic survey data with Kenneth Kidd, a geneticist at Yale University.

The genetic data was being used to be able to determine, from a blood sample, if someone had Uighur ancestry. Chinese scientists even filed a patent on the idea.

Backlash: Thermo Fisher’s role in China has been known for some time, thanks to reports by Human Rights Watch. In November, US Senator Marco Rubio called out the company in a tweet for “making lots of $ helping #Xinjiang authorities conduct mass detention ...” 

But the company seems to have buckled only because of scrutiny from the Times. Thermo Fisher announced on February 20 that it would stop sales of its "human identification technology" in Xinjiang, according to a statement.

Not just in China: The issue of genetic privacy is also of concern in the US, where some commercial databases of genetic information are being used by police to identify rapists and murderers. In theory, these tools could also be employed for ethnic profiling.

Deep Dive

Biotechnology and health

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

The quest to legitimize longevity medicine

Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.

There is a new most expensive drug in the world. Price tag: $4.25 million

But will the latest gene therapy suffer the curse of the costliest drug?

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.